This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comparative Study

. 2004 May;81(5):1428-9; author reply 1429.

doi: 10.1016/j.fertnstert.2004.02.005.

Output and input from the controversy: recombinant FSH versus hMG

PMID: 15136126
DOI: 10.1016/j.fertnstert.2004.02.005

Free article

Comparative Study

Output and input from the controversy: recombinant FSH versus hMG

Jerome H Check. Fertil Steril. 2004 May.

Free article

. 2004 May;81(5):1428-9; author reply 1429.

doi: 10.1016/j.fertnstert.2004.02.005.

Author

PMID: 15136126
DOI: 10.1016/j.fertnstert.2004.02.005

No abstract available

PubMed Disclaimer

Comment on

Effectiveness of human menopausal gonadotropin versus recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles: a meta-analysis.
van Wely M, Westergaard LG, Bossuyt PM, van der Veen F. van Wely M, et al. Fertil Steril. 2003 Nov;80(5):1086-93. doi: 10.1016/s0015-0282(03)02187-3. Fertil Steril. 2003. PMID: 14607553
Follitropin-alpha versus human menopausal gonadotropin in an in vitro fertilization program.
Goldfarb JM, Desai N. Goldfarb JM, et al. Fertil Steril. 2003 Nov;80(5):1094-9. doi: 10.1016/s0015-0282(03)02188-5. Fertil Steril. 2003. PMID: 14607554

Similar articles

Clinical efficacy of highly purified hMG versus recombinant FSH in IVF/ICSI cycles: a meta-analysis.
Jee BC, Suh CS, Kim YB, Kim SH, Moon SY. Jee BC, et al. Gynecol Obstet Invest. 2010;70(2):132-7. doi: 10.1159/000308458. Epub 2010 Apr 10. Gynecol Obstet Invest. 2010. PMID: 20389096 Review.
Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization-intracytoplasmic sperm injection patients.
Hompes PG, Broekmans FJ, Hoozemans DA, Schats R; FIRM group. Hompes PG, et al. Fertil Steril. 2008 Jun;89(6):1685-93. doi: 10.1016/j.fertnstert.2007.05.039. Epub 2007 Aug 6. Fertil Steril. 2008. PMID: 17681325 Clinical Trial.
Human menopausal gonadotropin and recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles.
van Wely M, Westergaard LG, Bossuyt PM, van der Veen F. van Wely M, et al. Fertil Steril. 2003 Nov;80(5):1121-2. doi: 10.1016/s0015-0282(03)02190-3. Fertil Steril. 2003. PMID: 14607560 No abstract available.
Effectiveness of human menopausal gonadotropin versus recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles: a meta-analysis.
van Wely M, Westergaard LG, Bossuyt PM, van der Veen F. van Wely M, et al. Fertil Steril. 2003 Nov;80(5):1086-93. doi: 10.1016/s0015-0282(03)02187-3. Fertil Steril. 2003. PMID: 14607553
Identifying real differences in live birth rates between HMG and rFSH in IVF.
Afnan M. Afnan M. Reprod Biomed Online. 2009;18 Suppl 2:25-30. doi: 10.1016/s1472-6483(10)60445-2. Reprod Biomed Online. 2009. PMID: 19406028 Review.

See all similar articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science